Vandortuzumab
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.5 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
Product Specifications
Product Name Alternative
DSTP-3086S Antibody; RG-7450 Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vandortuzumab.html
Purity
99.00
Molecular Weight
(145.5 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15160876 1 Vial
Lentiviral human WDR55 shRNA (UAS) - Lentiviral human WDR55 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
MBS1193443-01 0.02 mg (E-Coli)
Recombinant Aspergillus flavus Probable feruloyl esterase C (faeC)
Sign In for Pricing
View Details 
MBS1193443-02 0.1 mg (E-Coli)
Recombinant Aspergillus flavus Probable feruloyl esterase C (faeC)
Sign In for Pricing
View Details MBS1193443-03 0.02 mg (Yeast)
Recombinant Aspergillus flavus Probable feruloyl esterase C (faeC)
Sign In for Pricing
View Details